Maravai LifeSciences Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Maravai LifeSciences Holdings, Inc. (MRVI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.82 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-26
- Maravai LifeSciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.82M shares.
- Maravai LifeSciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.27M shares, a 32.83% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.71M shares, a 276.43% increase from fiscal 2021.
- Maravai LifeSciences Holdings, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 454.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|
| 2025-12-31 | 1.82M shares 10-K · filed 2026-02-26 |
| 2023-12-31 | 2.27M shares 10-K · filed 2024-02-29 |
| 2022-12-31 | 1.71M shares 10-K · filed 2023-02-28 |
| 2021-12-31 | 454.00K shares 10-K · filed 2022-03-01 |